Antithrombin Iii


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 49.2%
Kawasaki's Disease 12.7%
Acute Myeloid Leukaemia 7.9%
Cerebral Haemorrhage 6.3%
Ischaemic Stroke 6.3%
Lymphocytic Leukaemia 6.3%
C-reactive Protein Increased 3.2%
Haemorrhage Intracranial 3.2%
Antithrombin Iii Deficiency 1.6%
Hypoalbuminaemia 1.6%
Thrombocytopenia 1.6%
Hypertriglyceridaemia 25.0%
Loss Of Consciousness 25.0%
Pulmonary Embolism 25.0%
Ventricular Tachycardia 25.0%
Concomitant
Product Used For Unknown Indication 23.7%
Disseminated Intravascular Coagulation 13.5%
Prophylaxis 9.2%
Pneumonia 6.0%
Drug Use For Unknown Indication 4.7%
Infection Prophylaxis 4.4%
Anaesthesia 4.2%
Sepsis 4.1%
Gastric Ulcer 3.7%
Cardiac Failure 3.5%
Reflux Oesophagitis 3.5%
Hypertension 2.9%
Angina Pectoris 2.6%
Gastritis 2.6%
Acute Myeloid Leukaemia 2.3%
Cholestasis 2.3%
Bradycardia 1.8%
Pyrexia 1.8%
Stem Cell Transplant 1.8%
Hypotension 1.5%
Renal Impairment 10.3%
Thrombocytopenia 10.3%
Septic Shock 9.3%
Shock 9.3%
Pneumonia 7.2%
White Blood Cell Count Increased 7.2%
Haemorrhage 5.2%
Venoocclusive Liver Disease 4.1%
Ventricular Fibrillation 4.1%
Wound Dehiscence 4.1%
Left Ventricular Dysfunction 3.1%
Multi-organ Failure 3.1%
Prothrombin Time Prolonged 3.1%
Pyrexia 3.1%
Renal Failure 3.1%
Renal Failure Acute 3.1%
Sepsis 3.1%
Tachyarrhythmia 3.1%
Delirium 2.1%
Dysarthria 2.1%

Drug Data